title: International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis.
abstract: The association between the upper and lower airways has been recognised for almost 2000 years. Epidemiological data suggest that most asthma patients also suffer from allergic rhinitis, and that both diseases share similar trigger factors and pathophysiology. This IPCRG Guideline on the management of rhinitis in primary care is fully consistent with the ARIA guidelines. It highlights the treatment goals and the classification of the condition according to symptom frequency (intermittent or persistent) and severity (mild or moderate-severe). It covers the need for allergen avoidance, pharmacologic therapy including immunotherapy, alternative therapies, management of ocular symptoms, the management of co-existing allergic rhinitis and asthma, and the need for follow-up and ongoing care for patients with rhinitis.
authors.affiliation: Department of General Practice, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, AB25 2AY, UK. David@respiratoryresearch.org
authors.forename: David
authors.initials: D
authors.lastname: Price
authors.forename: Christine
authors.initials: C
authors.lastname: Bond
authors.forename: Jacques
authors.initials: J
authors.lastname: Bouchard
authors.forename: Rui
authors.initials: R
authors.lastname: Costa
authors.forename: Joseph
authors.initials: J
authors.lastname: Keenan
authors.forename: Mark L
authors.initials: ML
authors.lastname: Levy
authors.forename: Mari
authors.initials: M
authors.lastname: Orru
authors.forename: Dermot
authors.initials: D
authors.lastname: Ryan
authors.forename: Samantha
authors.initials: S
authors.lastname: Walker
authors.forename: Margaret
authors.initials: M
authors.lastname: Watson
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D002867:Chromones / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use; D011247:Pregnancy; D011320:Primary Health Care / Q000592:standards*; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*
chemical_list: D018926:Anti-Allergic Agents; D018680:Cholinergic Antagonists; D002867:Chromones; D005938:Glucocorticoids; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants